Shares of Dendreon Corp. (NASDAQ:DNDN) closed more than 16 percent higher on Friday. The company recently reported that sales of its prostate-cancer treatment Provenge climbed to $82 million in the fourth quarter. Shares are edging down .32 percent after the closing bell. Other pharmaceutical companies such as Regeneron Inc. (NASDAQ:REGN) and Jazz Pharmaceuticals (NASDAQ:JAZZ) also closed 8 percent and 9.4 percent higher, respectively.
After closing 2 percent lower, shares of Alcoa Inc. (NYSE:AA) are climbing slightly higher in extended trading. The company is scaling back smelting capacity and will report financial results on Monday.
Investor Insight: Are Investors Getting Physical With Gold and Silver?
Transocean Ltd. (NYSE:RIG) shares declined 1.13 percent on Friday, and continue to fall another .20 percent in late trading. The oil drilling firm announced Ricardo Rosa would leave the company as its chief financial officer. Greg Cauthen will replace Rosa next week. Shares of Chevron Corp. (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are ticking slightly higher in late trading.
Despite closing 3 percent higher, shares of Lululemon Athletica (NASDAQ:LULU) are falling more than 2 percent in extended trading. The company’s founder, Chip Wilson, will step down as chief innovation and branding officer at the end of January. Competitor Under Armour Inc. (NYSE:UA) is also heading lower after the closing bell, while Nike Inc. (NYSE:NKE) shares remain unchanged.
Don’t Miss: BlackBerry: Staring at the Face of Extinction.
To contact the reporter on this story: Eric McWhinnie at firstname.lastname@example.org
To contact the editor responsible for this story: Damien Hoffman at email@example.com